Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis

https://doi.org/10.1016/j.coph.2022.102264Get rights and content

Abstract

Gastro-esophageal reflux disease (GERD) occurs in about 25% of the general population. The complexity of the disease and the multiplicity of its clinical manifestations impair the availability of a singular diagnostic test. The majority of GERD patients do not have any endoscopically visible lesions, the so-called non-erosive reflux disease (NERD). This latter population consists of several subgroups characterized by: 1. excess of acid; 2. normal acid, but hypersensitivity to acid or weakly acidic reflux; 3. normal acid, but lack of any relationship between symptoms and reflux episodes. At present, 24-h impedance-pH monitoring represents the best diagnostic tool to detect abnormal reflux and to correlate symptoms to reflux episodes. Moreover, the recent adoption of novel impedance metrics, such as mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index, seem to be able to improve the diagnostic yield of 24-h impedance-pH monitoring, making this test the most accurate in diagnosis of GERD.

Introduction

Gastroesophageal reflux disease (GERD) is a chronic and benign condition, affecting up to 20% of the general population in western countries while it is less prevalent in Asian populations [1]. According to the Montreal classification [2], it develops when the reflux into the esophagus of gastric contents (meals and secretions) causes troublesome symptoms and/or complications.

Until the end of the second millennium, GERD was identified with erosive esophagitis (EE), but in the past two decades we have realized that the majority of patients with this illness do not present any inflammatory lesions of the distal part of the esophagus at endoscopy [3]. This non-erosive form of GERD has been named as NERD (non-erosive reflux disease) on the exclusive basis of the absence of endoscopic damage, but subsequent functional studies have clearly shown that it is markedly heterogeneous from a pathophysiological point of view, because we can distinguish various phenotypes [4]: patients with acid excess (true NERD); patients with normal acid, but positive correlation between heartburn and reflux episodes (reflux hypersensitivity) and patients with normal acid, but without any relationship between symptoms and reflux events (functional heartburn = FH). In other words, the most typical symptom of GERD, that is heartburn, can be due not only to acid, but also to other factors not depending on increased esophageal acid exposure [5].

Beyond the typical symptoms of GERD (heartburn and regurgitation), this disorder can manifest with extraesophageal symptoms (chronic cough, hoarseness, asthma), but this association has been questioned in last years, because it seems to be much less frequent than previously estimated [6].

Section snippets

Diagnosis of GERD

Taking into consideration the above complexity of the phenotypic characterization of GERD, the diagnosis of this disease remains difficult also in 2021, because we continue to complain the lack of a “gold standard” examination, which permits to assess with certainty the detection of gastroesophageal reflux as the cause of symptoms we generally attribute to GERD, but they are shared by many other disorders. As a consequence, we have to rely on many diagnostic options, which present advantages

Conclusions

Taking in mind that a “gold standard” test to diagnose this disease is still lacking, impedance-pH monitoring over 24 h is actually considered the best method to assess GERD and has contributed to reveal the heterogeneous pathophysiology of NERD patients, who represent the majority of GERD (about 70%). In particular, impedance-pH monitoring allows to categorize NERD patients in “true” NERD, reflux hypersensitivity and FH, thus helping to exclude the latter disorder from the NERD realm and

Authors’ contribution

EM, VS, ES: design of the study, data collection, writing of the manuscript, approving final version; MG, MF, MR, BB: data collection, writing of the manuscript, approving final version.

Guarantor of the article

Edoardo Savarino.

Financial support

None.

Conflict of interest statement

ES declares lecture fees from Takeda, Janssen, MSD, Abbvie, Malesci, Sofar, and consulting fees from BMS, Gilead, Takeda, Janssen, MSD, Reckitt Benckiser, Sofar, Unifarco, SILA, Oftagest, Diadema; the remaining authors have no disclosures.

References (62)

  • D. Sifrim et al.

    Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world

    Gut

    (2020 Oct)
  • H.B. El-Serag et al.

    Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

    Gut

    (2014)
  • N. Vakil et al.

    The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus

    Am J Gastroenterol

    (2006)
  • E. Savarino et al.

    NERD: an umbrella term including heterogeneous subpopulations

    Nat Rev Gastroenterol Hepatol

    (2013)
  • E. Savarino et al.

    The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy

    Am J Gastroenterol

    (2008)
  • M. Ghisa et al.

    Updates in the field of non-esophageal gastroesophageal reflux disorder

    Expet Rev Gastroenterol Hepatol

    (2019)
  • F. Pace et al.

    The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease

    Eur J Gastroenterol Hepatol

    (2009)
  • J. Dent et al.

    Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

    Gut

    (2010)
  • S. Roman et al.

    Eosinophilic oesophagitis: from physiopathology to treatment

    Dig Liver Dis

    (2013)
  • E.A. Bolier et al.

    Systematic review: questionnaires for assessment of gastroesophageal reflux disease

    Dis Esophagus

    (2015)
  • V. Stanghellini et al.

    Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies

    Digestion

    (2007)
  • A. de Leone et al.

    The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration

    Dig Liver Dis

    (2010)
  • P. Bytzer et al.

    Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease

    Clin Gastroenterol Hepatol

    (2012)
  • R.M. Zagari et al.

    Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study

    Gut

    (2008)
  • E. Savarino et al.

    Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease

    Aliment Pharmacol Ther

    (2011 Aug)
  • M. Ribolsi et al.

    Patients with definite and inconclusive evidence of reflux according to Lyon consensus display similar motility and esophagogastric junction characteristics

    J Neurogastroenterol Motil

    (2021 Oct 30)
  • M. Ribolsi et al.

    Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients

    Neuro Gastroenterol Motil

    (2020 Mar)
  • C.P. Gyawali et al.

    Ineffective esophageal motility: concepts, future directions, and conclusions from the Stanford 2018 symposium

    Neuro Gastroenterol Motil

    (2019 Sep)
  • C.P. Gyawali et al.

    Modern diagnosis of GERD: the Lyon consensus

    Gut

    (2018)
  • F.B. van Hoeij et al.

    Predictive value of routine esophageal high-resolution manometry for gastro-esophageal reflux disease

    Neuro Gastroenterol Motil

    (2015 Jul)
  • E. Savarino et al.

    A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring

    Dig Liver Dis

    (2020)
  • a

    Denotes first authors.

    View full text